L.E.A.F. Pharmaceuticals
L.E.A.F. Pharmaceuticals: A global leader in innovating and commercializing safe cancer therapies.
Founded
2014L.E.A.F. Pharmaceuticals: A global leader in innovating and commercializing safe cancer therapies.
L.E.A.F. Pharmaceuticals, founded with a mission to discover, develop, and commercialize innovative and safe cancer therapies, is a global pharmaceutical company focused on transforming cancer treatment. The company aims to lift and empower all families by providing cutting-edge solutions in oncology. Their product pipeline includes a range of novel therapies designed to target various forms of cancer, leveraging advanced scientific research and technology.
Notable figures affiliated with L.E.A.F. Pharmaceuticals include a distinguished management team and a panel of esteemed scientific and medical advisors. The company has achieved significant milestones in its research and development efforts, contributing to the advancement of cancer treatment options. Through its innovative approach, L.E.A.F. Pharmaceuticals has made a substantial impact on the global healthcare landscape, offering hope and improved outcomes for cancer patients worldwide.
Companies similar to L.E.A.F. Pharmaceuticals include Tigris Pharmaceuticals, Semafore Pharmaceuticals, Ascenta Therapeutics and Advanced Cancer Therapeutics.
L.E.A.F. Pharmaceuticals was founded in 2014.
L.E.A.F. Pharmaceuticals' headquarters is located in Woburn, MA, US.
L.E.A.F. Pharmaceuticals' most recent funding round was for $40.4M (USD) in August 2017.
As of Aug 7, 2017, L.E.A.F. Pharmaceuticals has disclosed funding of $40.4M (USD). Undisclosed round amounts are excluded.
L.E.A.F. Pharmaceuticals has 30 employees as of Feb 5, 2024.
Advanced Cancer Therapeutics
